Page results
-
Our annual members' meeting (AMM) brings together members, governors and staff, and is where our governors officially receive our annual report and accounts.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
Information about the Integrative Talking Therapies service at the Royal London Hospital for Integrated Medicine.
-
Information about staff who work in the Macmillan Support and Information Service.
-
The Neuroimmunology and CSF Laboratory at the Institute of Neurology, UCLH is a UKAS accredited medical laboratory No. 8045.
-
Latest news and developments in the Macmillan Support and Information Service
-
Events, classes and workshops at the Macmillan Support and Information Service (MSIS)
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
Information about clinic-based after-care following treatment for childhood or teenage cancer at UCLH.
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
File results
-
FOI/2024/0438 - IT electronic signature software service/ e-Signatures
-
FOI/2024/0439 - Digital dictation provider
-
FOI/2024/0440 - Patient reported outcome measures (PROMs) in oncology
-
FOI/2024/0450 - Trust-wide obesity and weight management strategy
-
FOI/2024/0455 - Information Governance structure
-
FOI/2024/0534 - NHS staff absence rates
-
FOI/2024/0537 - SHO doctor shifts covered by physician associates December 2023-May 2024
-
FOI/2024/0541 - Healthcare-associated infections (HAIs) 2022-2024
-
FOI/2024/0542 - Single-use medical items usage at Trust
-
FOI/2024/0458 - Infected blood products, patient numbers 2019/20-2023/24